Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study

BACKGROUND: The safety and efficacy outcome of elderly metastatic colorectal cancer (mCRC) patients fit enough to receive combination chemotherapy plus biological agents is an issue of growing interest. Also, gender-specific differential toxicity and efficacy of anti-epidermal growth factor receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Raimondi, A., Fucà, G., Leone, A.G., Lonardi, S., Antoniotti, C., Smiroldo, V., Amatu, A., Tampellini, M., Ritorto, G., Murialdo, R., Clavarezza, M., Zaniboni, A., Berenato, R., Ratti, M., Corallo, S., Morano, F., Di Bartolomeo, M., Di Maio, M., Pietrantonio, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379288/
https://www.ncbi.nlm.nih.gov/pubmed/34416469
http://dx.doi.org/10.1016/j.esmoop.2021.100246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379288/
https://www.ncbi.nlm.nih.gov/pubmed/34416469
http://dx.doi.org/10.1016/j.esmoop.2021.100246

Ejemplares similares